Latest Administration News

Epsilon Healthcare reports a strong rebound with a 73% revenue increase in the June quarter, driven by contract manufacturing and new pharmacy operations. The company is emerging from restructuring with renewed financial strength and growth prospects.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.

AVITA Medical reported a 13% revenue decline in Q3 2025 but improved cash efficiency and secured Medicare payment confirmations for RECELL®, positioning for growth in 2026.

Haranga Resources has launched the second phase of a 3,000-metre Aircore drilling campaign at its Ibel South Gold Project in Senegal, following promising high-grade gold results from its maiden program. The new drilling aims to confirm and expand mineralised zones ahead of a deeper 2026 drilling campaign.

Finaccess Restauración, S.L. has secured acceptances exceeding 90% in its takeover bid for Restaurant Brands New Zealand, setting the stage for compulsory acquisition of remaining shares and imminent delisting.

Javelin Minerals has initiated a significant capital consolidation, reducing its share count by a factor of 31, and is introducing a facility to help small shareholders sell untradeable parcels post-consolidation.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

TrivarX Limited has exercised its option to acquire the innovative Stabl-Im brain imaging technology, aiming to revolutionize early detection of brain tumours pending shareholder approval.

Medibank is set to acquire Better Medical, a network of 61 GP clinics across four states, for approximately $159 million, enhancing its primary care footprint and preventive health initiatives.

Altech Batteries confirms the strategic importance of its AMPower Agreement, enabling immediate sales and cash flow, while detailing a recent $6 million capital raising and addressing trading compliance issues.